Analysis of Hypodermic Needles Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Increasing at a CAGR of 4%, the global hypodermic needles market is valued at US$ 5.74 billion in 2023 and is thus projected to reach US$ 8.50 billion by the end of 2033. An increasing number of dental surgeries and the rising prevalence of chronic disorders are majorly driving the sales of hypodermic needles.
A hypodermic needle is a thin hollow metallic tubing instrument with a sharp edge that is used to inject medicines into the body system or extract fluids from the body, such as blood. Hypodermic needles are used in various procedures, including dental procedures, surgeries, drug delivery, vaccinations, and blood collection. The syringe comprises three components, including a long shaft, a bevel, and a hub, into which the needle is inserted.
Hypodermic needles are segmented into safety hypodermic needles and non-safety hypodermic needles. Global demand for safety needles is expected to increase at a CAGR of 4.5% from 2023 to 2033. Due to its built-in safety features, as well as technological advancements and innovation in the manufacture of multi-safety needles, the demand for safety hypodermic needles is increasing.
Decreased danger of needle stick injuries, which can lead to the spread of blood-borne infections such as HIV and the hepatitis B and C viruses, is another factor driving sales growth. Safety needles are more practical for everyday usage, reduce the danger of infection, and are cost-effective.
Since diabetic patients must take regular insulin doses to maintain health, there will be a large demand among those customers for painless or pain-free needles to prevent any discomfort or unease associated with painful needles. Thus, the demand for safety hypodermic needles is increasing at a healthy pace.
Hypodermic Needles Market Size (2023E)
US$ 5.74 Billion
Forecasted Market Value (2033F)
US$ 8.5 Billion
Global Market Growth Rate (2023 to 2033)
Dominating Regional Market
Key Companies Profiled
Don't Need a Global Report?
Save 40% on Country & Region specific reports
“Ongoing COVID-19 Vaccination Campaigns and ISO Standards Benefitting Hypodermic Needle Manufacturers”
Syringes and needles have been under the limelight as a result of the global immunization campaigns due to COVID-19. To ensure they adhere to internationally recognised standards for safety and quality, healthcare professionals must follow International Organization for Standardization (ISO) guidelines. With the increasing need for single-use needles & catheters for blood sampling, key players in the hypodermic needles market are taking advantage of commercial prospects.
Government regulations on the particular qualities and specifications for sterile single-use hypodermic syringes are becoming more and more known to stakeholders in the healthcare industry. To meet demands for vaccination programs and ongoing COVID-19 patient cases in hospitals, producers of hypodermic needles are sustaining strong supply chains. Medical needle producers can ensure that their products adhere to World Health Organization (WHO) guidelines by using international standards.
“Rising Prevalence of Chronic Disorders”
Increasing cases of chronic disorders such as cancer, diabetes, and cardiovascular disorders are boosting the sales of hypodermic needles. The increasing burden of infectious diseases, rising demand for injectable drugs, and technological advancements in needle manufacturing are boosting sales growth.
One of the most prevalent diseases in the world today is cancer. Syringes and needles for drug administration are in high demand due to the increasing rate of cancer cases, and this demand is anticipated to considerably contribute to the growth of the hypodermic needles market throughout the forecast period.
For managing blood sugar levels, the diabetic population needs insulin, which is often injected with the aid of a syringe and needle. Therefore, the need for needles and syringes is projected to increase due to the rising prevalence of diabetes.
“Growing Number of Hospital & Surgical Facilities”
Both industrialized and developing nations are witnessing growing hospitals and surgical facilities. Due to the growing patient base, there is a considerable need for medical or surgical gadgets at these surgical centres and hospitals.
Developing nations' healthcare systems have seen major advancements during the past ten years, particularly in China and India.
“High Use of Self-administrating Drugs”
Self-administered injectables are becoming more popular as a result of patients choosing to self-administer their medications. The most common disorders treated with these self-injecting devices are chronic diseases including diabetes or emergency conditions such as allergies. Self-administering injectables are useful in easing users' needle-related anxieties.
Females commonly administer injectable contraception to themselves to avoid the cost and inconvenience of clinic appointments. Contraceptives delivered via injection are safer than other methods. When used properly, they avoid pregnancy 99% of the time. These injections can be given during the menstrual cycle and also offer a defense against womb cancer and inflammatory illnesses of the pelvis.
Patients who have breast cancer, diabetes, liver tumours, or osteoporosis prefer to administer these injections themselves. In keeping with this, businesses are concentrating on creating cutting-edge self-administration tools. The demand for hypodermic needles is increasing as self-administering injectables are becoming more widely used.
“Development of Alternative Drug Delivery Methods”
Typically, patients preferred alternative drug delivery methods such as oral, topical, and nasal since injectables were invasive and uncomfortable. Oral drug delivery is the most used medication administration method since it is simple, practical, economical, safe, and acceptable. The above-mentioned considerations have led to an increase in alternative drug delivery methods being used globally.
Currently, one important industry for injectable drug delivery technologies is insulin injections. The introduction of inhalable insulin, however, might have a detrimental effect on the hypodermic needles industry because nasal drug delivery is painless and has a high patient compliance rate. The necessity for needles is also being hampered by the development of alternative delivery methods, such as oral anaemia therapy (by GlaxoSmithKline and Bayer).
Proteins and peptides have typically been supplied by the injectable mode of medication delivery due to their enormous molecular size and stability problems. Oral dosing of therapeutic proteins and peptides is now possible due to the recent development of smaller peptide molecules using intricate techniques such as nanotechnology.
“Rising Prevalence of Heart Disorders and Presence of Key Market Players”
Rising cases of cardiac disorders, rapid innovations in needle development, and the presence of key market players are some of the aspects boosting the sales of hypodermic needles in the United States. Also, the cases of diabetes are increasing rapidly in the United States, which is again driving sales growth.
“Rapidly Growing Cases of Neoplasms”
In the European market for hypodermic needles, Germany holds a significant position. The presence of well-established healthcare infrastructure, rising medical tourism, and increasing cases of infectious diseases are all boosting the sales of hypodermic needles in Germany.
Growing cases of neoplasms are some of the major factors driving sales growth. Increasing patient awareness regarding the availability of advanced injections and favourable reimbursement policies are also boosting the demand for hypodermic needles.
“Increasing Percentage of Senior Population”
Japan is one of the rapidly progressing markets in the Asia Pacific region. This can be attributed to the factors such as the rapidly growing rate of the senior population. Ageing gives rise to several disorders such as heart disorders, diabetes, and more.
Also, rising cases of obesity and lifestyle disorders are driving the demand for hypodermic needles. Poor diet, a sedentary lifestyle, and work stress are some of the factors increasing the risk of several disorders.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
“High Patient Admissions and Availability of Advanced Treatment Procedures”
Demand for hypodermic needles from hospitals is increasing at a rapid pace. This can be ascribed to the high intake of patient admissions and the presence of advanced healthcare systems.
Target patients prefer hospitals for treatment procedures due to the presence of skilled medical professionals and advanced technologies. Rapidly rising cases of chronic disorders are also increasing the demand for needles and syringes from hospitals.
According to Fact.MR, a market research and competitive intelligence provider, key players in the hypodermic market are focusing on developing advanced needles to maintain market position and earn more. Mergers, acquisitions, regional expansion, increasing local supply, and new product developments are some of the tactics adopted by the leading companies in the market.
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunitiesBuy Now
Get A Special pricing for start-ups and universitiesEnquiry Before Buying
- Humble, Yet Honored -
- Research Methodology -
An Adaptive Approach to Modern-day Research NeedsGet Methodology
- Related Reports -
The market for hypodermic needles is valued at US$ 5.47 billion in 2023.
The global hypodermic needles market is projected to reach US$ 8.5 billion by 2033.
Global demand for hypodermic needles is expected to increase at a CAGR of 4% from 2023 to 2033.
Rapid advancements such as the introduction of shorter needles are some of the factors driving product sales growth.
Braun Melsungen AG, Terumo Corporation, BD, and Cardinal Health are leading hypodermic needle manufacturing companies.
Need An Exclusive Report For Your Unique Requirement?